Fluorodeoxyglucose positron emission tomography improves preoperative staging of resectable lung metastasis

Journal of Thoracic and Cardiovascular Surgery

Volumn 126, Issue 6, 2003, Pages 1906-1910

  Pastorino, Ugo ^a   Veronesi, G ^b   Landoni, C ^c   Leon, M ^b   Picchio, M ^c   Solli, P G ^a   Leo, F ^b   Spaggiari, L ^b   Pelosi, G ^b   Bellomi, M ^b   Fazio, F ^c  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^c CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; LUNG CANCER; LUNG METASTASIS; LUNG RESECTION; LUNG SURGERY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL TIME;

EID: 9144258567     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(03)00211-3     Document Type: Article

References (14)

1. Rusch VW. Pulmonary metastasectomy. Current indication. Chest. 1995;107:S322-31.
2. Pastorino U. History of the surgical management of pulmonary metastases and development of the International Registry. Semin Thorac Cardiovasc Surg. 2002;14:18-28.
3. Girard P, Baldeyrou P, Le Chevalier T, Le Cesne A, Brigandi A, Grunenwald D. Surgery for pulmonary metastases. Who are the 10-year survivors? Cancer. 1994;74:2791-7.
4. Pastorino U, Buyse M, Friedel G, et al. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. The International Registry of Lung Metastases. J Thorac Cardiovasc Surg. 1997:113:37-49.
5. Pieterman RM, van Putten JWG, Meuzelaar JJ, et al. Preoperative staging of non-small-cell lung cancer with positron emission tomography. N Engl J Med. 2000;343:254-61.
6. Saunders C, Dussek JE, O'Doherty MJ, Maisey MN. Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography in the staging of lung cancer. Ann Thorac Surg. 1999;67:790-7.
7. Gupta NC, Graeber GM, Bishop HA. Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<1 cm), intermediate (1 to 3 cm) and large (>3 cm) lymph node lesions. Chest. 2000;117:773-8.
8. Kalff VV, Hicks RJ, MacManus P, et al. Clinical impact of (18) F fluorodeoxyglucose positron emission tomography in patients with non-small-cell-lung cancer: a prospective study. J Clin Oncol. 2001;19:111-8.
9. Loehe F, Kobinger S, Hatz RA, Helmberger T, Lohers U, Fuerst H. Value of systematic mediastinal lymph node dissection during pulmonary metastasectomy. Ann Thorac Surg. 2001;72:225-9.
10. Okumura S, Kondo H, Tsuboi M, et al. Pulmonary resection for metastatic colorectal cancer: experiences with 159 patients. J Thorac Cardiovasc Surg. 1996;112:867-74.
11. Lucas JD, Doherty MJ, Wong JCH, et al. Evaluation of fluorodeoxy-glucose positron emission tomography in the management of soft-tissue sarcomas. J Bone Joint Surg. 1998;80B:441-7.
12. Lowe VJ, Fletchetr JW, Gobar L, et al. Prospective investigation of positron emission tomography in lung nodules. J Clin Onc. 1998;16:1075-84.
13. Coleman RE. PET in lung cancer. J Nucl Med. 1999;40:818-20.
14. Kutlu CA, Pastorino U, Maisey M, Goldstraw P. Early experience with PET scanning in thoracic tumors. J Cardiovasc Surg. 2001;42:403-10.